Stay updated with breaking news from Robert Molander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Infant Bacterial Therapeutics, Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2021
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2021, among other things, the following was resolved: adoption of the annual reportthat no dividend is givendischarge
Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, May 4, 2021. In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend this year’s Meeting in person or by proxy. Right to participate In order to participate in the Annual General Meeting (AGM) shareholders must be recorded in the shareholder register maintained by Euroclear Sweden AB no...
Infant Bacterial Therapeutics AB: Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Tuesday, May 4, 2021. In light of the coronavirus, the Annual General Meeting is conducted through advance voting pursuant to temporary regulations. Therefore, it will not be possible to attend this year's Meeting in person or by proxy. Right to participate In order to participate in the Annual General Meeting (AGM) shareholders must be recorded in the shareholder register maintain...